22 results
8-K
EX-3.1
VYNE
VYNE Therapeutics Inc
10 Feb 23
Material Modifications to Rights of Security Holders
5:01pm
8-K
EX-3.1
VYNE
VYNE Therapeutics Inc
17 Jan 23
Amendments to Articles of Incorporation or Bylaws
5:15pm
10-Q
2022 Q3
EX-3.1
VYNE
VYNE Therapeutics Inc
Quarterly report
14 Nov 22
4:15pm
10-Q
2022 Q3
EX-3.2
VYNE
VYNE Therapeutics Inc
Quarterly report
14 Nov 22
4:15pm
10-K
2021 FY
EX-3.1
VYNE
VYNE Therapeutics Inc
Annual report
17 Mar 22
4:10pm
8-K
EX-3.1
kk3i1e
19 Jul 21
Amendments to Articles of Incorporation or Bylaws
5:11pm
8-K
EX-3.1
t48pzrsu7
12 Feb 21
Material Modifications to Rights of Security Holders
5:00pm
8-K
EX-3.2
w6t4354zt7jyf20712i
8 Sep 20
Menlo Therapeutics Announces Completion of Corporate Name Change to VYNE Therapeutics
8:21am
8-K
EX-3.1
w4vs9x9zjf6 x8t6
8 Sep 20
Menlo Therapeutics Announces Completion of Corporate Name Change to VYNE Therapeutics
8:21am
8-K
EX-3.1
mntg y3iqe8pa81
6 Apr 20
Menlo Therapeutics Announces Results from Two Phase 3 Clinical Trials of Serlopitant for the Treatment of Pruritus Associated with Prurigo Nodularis
9:00am
8-K
EX-3.1
pi5hlldy9mvd1 06pytk
29 Jan 18
Menlo Therapeutics Inc. Announces Pricing of Initial Public Offering of Common Stock
12:00am
8-K
EX-3.2
uirhu 23cfcrh
29 Jan 18
Menlo Therapeutics Inc. Announces Pricing of Initial Public Offering of Common Stock
12:00am
S-1/A
EX-3.2
u6ft8uq1ovn 4olqalth
12 Jan 18
IPO registration (amended)
12:00am
S-1
EX-3.3
ojrzomv7l8 91x
28 Dec 17
IPO registration
12:00am
S-1
EX-3.1
s9ixtbqro2e2
28 Dec 17
IPO registration
12:00am
S-1
EX-3.5
i1cv6fz1
28 Dec 17
IPO registration
12:00am
S-1
EX-3.4
k83pje 7xj5n502
28 Dec 17
IPO registration
12:00am